journal article·2018-11-05Open access

Intrarenal delivery of bFGF-loaded liposome under guiding of ultrasound-targeted microbubble destruction prevent diabetic nephropathy through inhibition of inflammation

Wen-Shuang Sheng, He-Lin Xu, Lei Zheng, Yuan-Di Zhuang, Li-Zhuo Jiao, Jia-Feng Zhou, De-Li ZhuGe, Ting-Ting Chi, Ying-Zheng Zhao, Li Lan

Abstract

Basic fibroblast growth factor (bFGF) has shown great therapeutic effects for diabetic nephropathy (DN). However, its clinical applications are limited due to its short half-life, low stability and poor penetration. Herein, a bFGF-loaded liposome (bFGF-lip) was constructed and combined with ultrasound-targeted microbubble destruction (UTMD) to overcome these drawbacks. bFGF-lip exhibited spherical morphology with a diameter of 171.1 ± 14.2 nm and a negative zeta potential of -5.15 ± 2.08 mV, exhibiting a sustained-release profile of bFGF. DN rat models were successfully induced by streptozotocin. After treatment with bFGF-lip + UTMD, the concentration of bFGF in kidney of DN rats was significantly enhanced in comparison with free bFGF treatment. Additionally, the morphology and the function of the kidneys were obviously recovered after bFGF-lip + UTMD treatment as shown by ultrasonography and histological analyse. The molecular mechanism was associated with the inhibition of renal inflammation. After treatment with bFGF-lip + UTMD, the activation of NF-κB was obviously reduced in the renal tissues, and downstream inflammatory mediators including TGF-β1, MCP-1, IL-6 and IL-1β were also down regulated. In addition, inflammation-induced cellular apoptosis of renal tubular cells was also significantly inhibited by detecting Bax, caspase-3 and Bcl-2. Therefore, bFGF-lip in combination with UTMD might be a potential strategy to reverse the progression of early DN.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Dermatologic Treatments and Research · Acute Kidney Injury Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ultrasound, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province, China;

School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China

Funding

Zhejiang Provincial Natural Science Foundation of China · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.3181/0705-MR-13410.3181/0705-MR-134 ↗
2. 10.4239/wjd.v3.i1.710.4239/wjd.v3.i1.7 ↗
3. 10.1042/CS2008039410.1042/CS20080394 ↗
4. 10.1016/j.semnephrol.2010.03.00710.1016/j.semnephrol.2010.03.007 ↗
5. 10.1152/ajprenal.00090.201110.1152/ajprenal.00090.2011 ↗
6. 10.1038/labinvest.2011.9310.1038/labinvest.2011.93 ↗
7. 10.1146/annurev.immunol.021908.13264110.1146/annurev.immunol.021908.132641 ↗
8. 10.1016/j.bbadis.2011.03.00810.1016/j.bbadis.2011.03.008 ↗
9. 10.1016/j.jaut.2008.04.01210.1016/j.jaut.2008.04.012 ↗
10. 10.1016/j.cbi.2014.05.01110.1016/j.cbi.2014.05.011 ↗
11. 10.1038/nrneph.2011.5110.1038/nrneph.2011.51 ↗
12. 10.1517/14728222.2011.57536010.1517/14728222.2011.575360 ↗
13. 10.1080/15548627.2015.111517310.1080/15548627.2015.1115173 ↗
14. 10.1159/00047921210.1159/000479212 ↗
15. 10.1242/jcs.0116310.1242/jcs.01163 ↗
16. 10.1016/j.molimm.2011.03.01510.1016/j.molimm.2011.03.015 ↗
17. 10.1152/ajpregu.00023.200610.1152/ajpregu.00023.2006 ↗
18. 10.1111/jcmm.1320310.1111/jcmm.13203 ↗
19. 10.1152/ajprenal.00720.201210.1152/ajprenal.00720.2012 ↗
20. 10.1038/srep3647410.1038/srep36474 ↗
21. Zhao YZ · Int J Nanomedicine · 2016 · 11 · 675
22. 10.1016/j.jconrel.2014.04.05410.1016/j.jconrel.2014.04.054 ↗
23. 10.1080/21691401.2017.129064710.1080/21691401.2017.1290647 ↗
24. 10.1016/j.ijbiomac.2010.08.01010.1016/j.ijbiomac.2010.08.010 ↗
25. Gokce EH · Int J Nanomedicine · 2012 · 7 · 5109
26. 10.1016/j.jconrel.2005.08.02510.1016/j.jconrel.2005.08.025 ↗
27. 10.1002/jgm.63210.1002/jgm.632 ↗
28. 10.1097/01.ASN.0000067632.04658.B810.1097/01.ASN.0000067632.04658.B8 ↗
29. 10.1002/smll.20080080610.1002/smll.200800806 ↗
30. 10.1016/j.ultrasmedbio.2013.12.00610.1016/j.ultrasmedbio.2013.12.006 ↗
31. 10.1016/j.ijpharm.2017.06.07010.1016/j.ijpharm.2017.06.070 ↗
32. 10.7863/jum.2008.27.4.61110.7863/jum.2008.27.4.611 ↗
33. 10.7863/jum.2008.27.11.160710.7863/jum.2008.27.11.1607 ↗
34. Kinns J · Vet Radiol Ultrasound · 2010 · 51 · 168
35. 10.1016/j.addr.2010.10.00210.1016/j.addr.2010.10.002 ↗
36. 10.1016/j.transproceed.2009.03.02910.1016/j.transproceed.2009.03.029 ↗
37. 10.1111/j.1755-5922.2010.00218.x10.1111/j.1755-5922.2010.00218.x ↗
38. 10.1016/j.lab.2005.05.00710.1016/j.lab.2005.05.007 ↗
39. 10.1016/j.pbb.2010.12.01410.1016/j.pbb.2010.12.014 ↗
40. 10.1155/2016/831928310.1155/2016/8319283 ↗
41. 10.1097/WNR.000000000000094010.1097/WNR.0000000000000940 ↗
42. 10.1093/ndt/16.suppl_6.8610.1093/ndt/16.suppl_6.86 ↗
43. 10.1016/S0735-1097(00)01210-910.1016/S0735-1097(00)01210-9 ↗
44. 10.1007/s11547-007-0121-010.1007/s11547-007-0121-0 ↗
45. 10.3233/CH-15196710.3233/CH-151967 ↗
46. 10.1038/ki.1983.7110.1038/ki.1983.71 ↗
47. 10.1148/radiol.252308035110.1148/radiol.2523080351 ↗
48. 10.1042/CS2012019810.1042/CS20120198 ↗
49. 10.1111/j.1523-1755.2004.00367.x10.1111/j.1523-1755.2004.00367.x ↗
50. 10.2353/ajpath.2007.06093710.2353/ajpath.2007.060937 ↗
51. 10.2174/15733990878350236110.2174/157339908783502361 ↗
52. Choudhary N · Iran J Kidney Dis · 2008 · 2 · 72
53. 10.1016/j.clinbiochem.2010.11.00410.1016/j.clinbiochem.2010.11.004 ↗
54. 10.1096/fj.04-2591hyp10.1096/fj.04-2591hyp ↗
55. 10.1016/j.freeradbiomed.2007.10.05510.1016/j.freeradbiomed.2007.10.055 ↗
56. 10.1097/01.ASN.0000033611.79556.AE10.1097/01.ASN.0000033611.79556.AE ↗
57. 10.18632/oncotarget.2043410.18632/oncotarget.20434 ↗